P

Pushpanjali

Active Director Director DIN 08403419
DIN 08403419 First appointment Mar 2019 Primary industry Business Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2019
Shareholding value •••• Premium profile

About Pushpanjali

Data last updated:

Pushpanjali is a Director at Rantas Pharmaceuticals Private Limited (since 2019). The company operates in Business Services. Rantas Pharmaceuticals Private Limited reported revenue of ₹23.4 Lakh (FY 2025).

DIN 08403419
Primary Designation Director
Industry Business Services
First Appointment 28 Mar 2019
Oldest Company Age 7 yrs
Largest company Rantas Pharmaceuticals Private Limited · ₹23.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Mar 20192019₹23.4 Lakh (FY 2025)Active

Board colleagues of Pushpanjali

Directorship timeline

Open interactive timeline →
Rantas Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pushpanjali

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pushpanjali

Pushpanjali currently holds 1 directorship: Rantas Pharmaceuticals Private Limited (Director, since 28 Mar 2019, revenue ₹23.4 Lakh (FY 2025)).

Pushpanjali was first appointed on 28 Mar 2019 as Director at Rantas Pharmaceuticals Private Limited.

The current boards of Pushpanjali's companies include Ranjit Kumar Sahani (Rantas Pharmaceuticals Private Limited), Sneha Raj (Rantas Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available